Pulmonary fungal infection with yeasts and pneumocystis in patients with hematological malignancy

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Annals medicus

• Publication date

  2005-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/07853890510037374PMID 16019724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aspergillosis

  2005cited by this paper
• Guidelines for treatment of candidiasis.

  2004cited by this paper
• Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

  2004cited by this paper
• Infections due to emerging and uncommon medically important fungal pathogens.

  2004cited by this paper
• Cryptococcosis in patients with hematologic malignancies. A report from GIMEMA-infection.

  2004cited by this paper
• Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.

  2004influential reference
• Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study

  2004cited by this paper
• Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp.

  2004cited by this paper
• Effect of tissue penetration on AmBisome efficacy.

  2003cited by this paper
• Increase in aspergillosis and severe mycotic infection in patients with leukemia and MDS: Comparison of the data from the Annual of the Pathological Autopsy Cases in Japan in 1989, 1993 and 1997

  2003cited by this paper
• Voriconazole treatment for less-common, emerging, or refractory fungal infections.

  2003cited by this paper
• Pneumocystis carinii pneumonia in patients with hematologic malignancies: a descriptive study.

  2003cited by this paper
• Multidrug-Resistant Trichosporon asahii Isolates Are Susceptible to Voriconazole

  2003cited by this paper
• Catheter-Related Sepsis Due to Rhodotorula glutinis

  2003cited by this paper
• Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study.

  2003cited by this paper
• Pneumonia due to Candida krusei.

  2002cited by this paper
• Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

  2002cited by this paper
• Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy‐based study involving 720 patients with haematological malignancy

  2002cited by this paper
• Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.

  2002cited by this paper
• Comparison of caspofungin and amphotericin B for invasive candidiasis.

  2002cited by this paper
• HRCT findings of chest complications in patients with leukemia

  2002cited by this paper
• State-of-the-art review of pulmonary fungal infections.

  2002cited by this paper
• Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres

  2002influential reference
• Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors.

  2002cited by this paper
• A New Name for Pneumocystis from Humans and New Perspectives on the Host-Pathogen Relationship

  2002cited by this paper
• Invasive infection due to penicillium species other than P. marneffei.

  2002cited by this paper
• Pulmonary Cryptococcosis: CT and Pathologic Findings

  2002cited by this paper
• Pulmonary candidiasis in patients with cancer: an autopsy study.

  2002cited by this paper
• Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate.

  2002cited by this paper
• Rhodotorula septicemia: case report and minireview.

  2001cited by this paper
• Cryptococcosis in patients with cancer.

  2001cited by this paper
• A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia.

  2001cited by this paper
• Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

  2001cited by this paper
• Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program.

  2001cited by this paper
• Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.

  2001cited by this paper
• Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial Therapy

  2001cited by this paper
• Trichosporon species infection in bone marrow transplanted patients.

  2001cited by this paper
• The use of adjuvant interferon-gamma therapy for hepatosplenic Blastoschizomyces capitatus infection in a patient with leukemia.

  2000cited by this paper
• [Cryptococcus neoformans infection in hematologic malignancies].

  2000cited by this paper
• Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts

  2000cited by this paper
• Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes

  2000cited by this paper
• Concurrent Pneumocystis carinii and cytomegalovirus pneumonia after autologous peripheral blood stem cell transplantation

  1999cited by this paper
• Pneumocystis pneumonia, an immunodeficiency-dependent disease (IDD): a critical historical overview.

  1999cited by this paper
• Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty‐first century

  1999cited by this paper
• Imaging features of Pneumocystis carinii pneumonia.

  1999cited by this paper
• Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol

  1999cited by this paper
• Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

  1999cited by this paper
• Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

  1999cited by this paper
• The changing face of Pneumocystis carinii pneumonia in AIDS patients.

  1999cited by this paper
• Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group.

  1999cited by this paper
• The epidemiology and prevention of invasive aspergillosis.

  1998cited by this paper
• Invasive aspergillosis.

  1998cited by this paper
• Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

  1998cited by this paper
• Cryptococcosis in Hodgkin's disease: description of two cases and review of the literature

  1998cited by this paper
• Utility of Routine Testing of Bronchoalveolar Lavage Fluid for Cryptococcal Antigen

  1998influential reference
• Pneumocystis carinii: the art and science of survival in the hostile environment of the alveolar spaces.

  1998cited by this paper
• Geotrichum capitatum septicaemia in neutropenic patients: case report and review of the literature

  1998cited by this paper
• Pneumocystis pneumonia: clinical presentation and diagnosis in patients with and without acquired immune deficiency syndrome.

  1998cited by this paper
• Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.

  1998cited by this paper
• Treatment and prophylaxis of Pneumocystis carinii pneumonia.

  1998cited by this paper
• Cryptococcosis: an unusual opportunistic infection complicating B cell lymphoproliferative disorders.

  1998cited by this paper
• An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group.

  1998cited by this paper
• The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients.

  1998cited by this paper
• Efficacy of MK-991 (L-743,872), a Semisynthetic Pneumocandin, in Murine Models ofPneumocystis carinii

  1998cited by this paper
• Infections in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine

  1998cited by this paper
• Fatal Penicillium citrinum pneumonia with pericarditis in a patient with acute leukemia

  1997cited by this paper
• Risk factors and attributable mortality associated with superinfections in neutropenic patients with cancer.

  1997cited by this paper
• [Slow-resolution pneumonia: radiologic and tomodensitometric features].

  1997cited by this paper
• Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.

  1997cited by this paper
• Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.

  1997cited by this paper
• Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation.

  1997cited by this paper
• Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study.

  1997cited by this paper
• Comparison of Three Regimens for Treatment of Mild to Moderate Pneumocystis carinii Pneumonia in Patients with AIDS: A Double-Blind, Randomized Trial of Oral Trimethoprim-Sulfamethoxazole, Dapsone-Trimethoprim, and Clindamycin-Primaquine

  1996cited by this paper
• Hospital-acquired candida and aspergillus pneumonia--diagnostic approaches and clinical findings.

  1996cited by this paper
• Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia

  1996cited by this paper
• Disseminated Geotrichum capitatum infection with predominant liver involvement in a patient with non Hodgkin's lymphoma.

  1996cited by this paper
• Opportunistic pulmonary infections with fludarabine in previously treated patients with low‐grade lymphoid malignancies: A role for pneumocystis carinii pneumonia prophylaxis

  1995cited by this paper
• Infections in patients with chronic adult T-cell leukemia/lymphoma: case report and review.

  1995cited by this paper
• Cryptococcal empyema: case report and review.

  1995cited by this paper
• Importance of Candida species other than C. albicans as pathogens in oncology patients.

  1995cited by this paper
• Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS.

  1995cited by this paper
• Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases.

  1995cited by this paper
• Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity

  1995cited by this paper
• Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen.

  1995cited by this paper
• Role of Pneumocystis carinii DNA amplification by PCR on the diagnosis of Pneumocystis carinii pneumonia in patients with haematologic malignant diseases: report of four cases.

  1995cited by this paper
• Comparison of histologic stains in the diagnosis of Pneumocystis carinii.

  1995cited by this paper
• Pulmonary fungal infections in immunocompromised patients: incidence and risk factors

  1994cited by this paper
• Pulmonary Manifestations of Cryptococcosis in Patients with AIDS: CT Features

  1994cited by this paper
• [Systemic fungal infections in hematologic neoplasms. An autopsy study of 1,053 patients].

  1994cited by this paper
• Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis.

  1994cited by this paper
• Comparison of commercial kits for detection of cryptococcal antigen

  1994cited by this paper
• DisseminatedTrichosporon beigelii infection in patients with malignant diseases: Immunohistochemical study and review

  1994cited by this paper
• Clinical epidemiological study of 171 cases of cryptococcosis.

  1994cited by this paper
• Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.

  1994cited by this paper
• Evolving risk factors for invasive fungal infections--all neutropenic patients are not the same.

  1994cited by this paper
• Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis

  1994influential reference
• Pneumocystis carinii pneumonia in patients with cancer. An increasing incidence

  1993cited by this paper
• Mucormycosis in the BMT population.

  1993cited by this paper
• Mucormycosis in the BMT population

  1993cited by this paper
• Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience.

  1993cited by this paper

• Invasive Pulmonary Aspergillosis (IPA)- A study of risk factors, Diagnostic modalities and role of galactomannan antigen detection.

  2025cites this paper
• Prevalence and predictors of pulmonary fungal infections in patients with acute leukemia and aggressive lymphomas: Implications for cancer care in developing countries

  2021cites this paper
• Fungal Isolates of the Respiratory Tract in Symptomatic Patients Hospitalized in Pulmonary Units: A Mycological and Molecular Epidemiologic Study

  2020cites this paper
• Pneumocystis jirovecii Pneumonia in Children with Hematological Malignancies: Diagnosis and Approaches to Management

  2020cites this paper
• Pneumocystis jirovecii Pneumonia in Patients with Nephrotic Syndrome: Application of Lymphocyte Subset Analysis in Predicting Clinical Outcomes

  2020cites this paper
• Cryptococcosis in Patients with Hematologic Diseases

  2018cites this paper
• Prevention of Infections in Patients with Hematological Malignancies

  2017cites this paper
• Catheter-Related Bloodstream Infections

  2017cites this paper
• Yeast Infections After Haematopoietic Stem Cell Transplantation

  2016cites this paper
• Fungal Infections in Cancer Patients

  2014cites this paper
• 25 – Miscellaneous Infections Caused by Fungi and Pneumocystis

  2014cites this paper
• Increasing Pneumocystis Pneumonia, England, UK, 2000–2010

  2013cites this paper
• Prevention of Infections in Patients with Hematological Malignancies

  2012cites this paper
• Uncommon yeast infections in hematological patients: from diagnosis to treatment

  2011cites this paper
• Pneumocystose pulmonaire en dehors de l’infection à VIH

  2010cites this paper
• Diagnostic Bronchoalveolar Lavage (BAL) for Pulmonary Fungal Infections in Critically Ill Children

  2008cites this paper
• Therapeutic Efficacy of a Conjugate Vaccine Containing a Peptide Mimotope of Cryptococcal Capsular Polysaccharide Glucuronoxylomannan

  2008cites this paper
• Combined Voriconazole Plus Caspofungin Therapy for the Treatment of Probable Geotrichum Pneumonia in a Leukemia Patient

  2008cites this paper
• Drug Target Discovery Through Analysis of Laccase Regulatory Networks of Cryptococccus neoformans

  2008cites this paper
• Role of a CUF1/CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans.

  2007cites this paper
• Pneumocystis Pneumonia in Non-AIDS Immunocompromised Patients

  2007cites this paper
• Impact of Zygomycosis on Microbiology Workload: a Survey Study in Spain

  2007cites this paper
• Jack o'Lantern--scarier than you think!

  2006cites this paper
• Fungal respiratory disease

  2006cites this paper